These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10244540)

  • 1. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed current good manufacturing practice and supplemental regulations.
    Korun FD
    Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 5. A summarized discussion of current good manufacturing practice regulations.
    Allen LV
    Int J Pharm Compd; 2013; 17(3):210-9. PubMed ID: 24046937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 7. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 8. Dilemmas in compounding for the veterinary teaching hospital.
    Kemp DT
    J Am Vet Med Assoc; 1994 Jul; 205(2):263-7. PubMed ID: 7928595
    [No Abstract]   [Full Text] [Related]  

  • 9. Compounding pharmaceuticals for investigational use.
    Tamer HR; Sweet BV
    Am J Health Syst Pharm; 2002 Sep; 59(18):1716-9. PubMed ID: 12298108
    [No Abstract]   [Full Text] [Related]  

  • 10. Compounding and repackaging--a need for complete records.
    Proksch RA
    Hosp Pharm; 1980 Jul; 15(7):344-5, 349-50, 352-5. PubMed ID: 10247655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 12. Policy and procedure manual. Drug recall program.
    Curr Concepts Hosp Pharm Manage; 1984; 6(3):19. PubMed ID: 10267189
    [No Abstract]   [Full Text] [Related]  

  • 13. Compounding botanicals: a legal perspective.
    Valentino JG; Bormel FG
    J Am Pharm Assoc (Wash); 1999; 39(4):537-44. PubMed ID: 10467820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal restrictions on compounding.
    Geyer RE
    J Am Vet Med Assoc; 1994 Jul; 205(2):241-2. PubMed ID: 7928588
    [No Abstract]   [Full Text] [Related]  

  • 15. Anchors away: the Food and Drug Administration's use of disgorgement abandons legal moorings.
    Vodra WW; Levine AN
    Food Drug Law J; 2004; 59(1):1-30. PubMed ID: 15190923
    [No Abstract]   [Full Text] [Related]  

  • 16. States boards of pharmacy compounding guidelines.
    Work DR
    J Am Vet Med Assoc; 1994 Jul; 205(2):254-5. PubMed ID: 7928592
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I. Federal regulations concerning use of asbestos filters in manufacturing parenteral drugs.
    Casola AR
    Bull Parenter Drug Assoc; 1975; 29(5):216-8. PubMed ID: 1182330
    [No Abstract]   [Full Text] [Related]  

  • 19. The authority of a court to order disgorgement for violations of the Current Good Manufacturing Practices requirement of the Federal Food, Drug, and Cosmetic Act.
    King E; Walsh EM
    Food Drug Law J; 2003; 58(2):149-68. PubMed ID: 12866550
    [No Abstract]   [Full Text] [Related]  

  • 20. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.